全氟丁烷微泡对肝细胞癌射频消融术中蒸汽爆裂现象的影响及其临床意义
本回顾性研究纳入90例连续接受经皮射频消融作为一线治疗的单一肝细胞癌患者,比较术中使用全氟丁烷微泡(Sonazoid®)与未使用者的蒸汽爆裂现象发生率及治疗结局。多变量分析显示使用Sonazoid®是蒸汽爆裂现象缺失的唯一显著因素(OR=0.10,p=0.048),但两组累积局部肿瘤进展和无病生存期无显著差异(p=0.479和p=0.424)。
要点
- 使用Sonazoid®与射频消融术中蒸汽爆裂现象缺失显著相关(OR=0.10,p=0.048)。
- 蒸汽爆裂现象总体发生率为25.8%(24/93)。
- 蒸汽爆裂现象的存在与否不影响累积局部肿瘤进展和无病生存期。
关键影像表现/征象
- 蒸汽爆裂现象定义为术中超声在消融区内探测到可听见的声音同时伴有突然爆裂。
- 蒸汽爆裂组24例中仅1例(4.2%)使用Sonazoid®,非蒸汽爆裂组69例中15例(21.7%)使用Sonazoid®。
诊断标准与关键数值
- 使用Sonazoid®是蒸汽爆裂现象缺失的唯一显著因素(OR=0.10,p=0.048)。
- 两组累积局部肿瘤进展比较p=0.479,无病生存期比较p=0.424,均无显著差异。
临床应用与阅片要点
- 术中使用Sonazoid®可能有助于抑制射频消融过程中的蒸汽爆裂现象。
- 蒸汽爆裂现象的存在与否可能不影响局部肿瘤进展和无病生存期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the effect of perfluorobutane microbubbles (Sonazoid®, GE Healthcare) on steam popping during radiofrequency (RF) ablation for treating hepatocellular carcinoma (HCC), and to assess whether popping affects treatment outcomes.
MATERIALS AND METHODS: The institutional review board approved this retrospective study, which included 90 consecutive patients with single HCC, who received percutaneous RF ablation as the first-line treatment. The patients were divided into two groups, based on the presence or absence of the popping phenomenon, which was defined as an audible sound with a simultaneous sudden explosion within the ablation zone as detected via ultrasonography during the procedure. The factors contributing to the popping phenomenon were identified using multivariable logistic regression analysis. Local tumor progression (LTP) and disease-free survival (DFS) were assessed using the Kaplan-Meier method with the log-rank test for performing comparisons between the two groups.
RESULTS: The overall incidence of the popping phenomenon was 25.8% (24/93). Sonazoid® was used in 1 patient (4.2%) in the popping group (n = 24), while it was used in 15 patients (21.7%) in the non-popping group (n = 69). Multivariable analysis revealed that the use of Sonazoid® was the only significant factor for absence of the popping phenomenon (odds ratio = 0.10, p = 0.048). There were no significant differences in cumulative LTP and DFS between the two groups (p = 0.479 and p = 0.424, respectively).
CONCLUSION: The use of Sonazoid® has a suppressive effect on the popping phenomenon during RF ablation in patients with HCC. However, the presence of the popping phenomenon may not affect clinical outcomes.
引用
- Jeong DY, Kang TW, Min JH, et al. Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma: Suppression of Steam Popping and Its Clinical Implication. Korean J Radiol. 2020. PMID: 32691543. doi:10.3348/kjr.2019.0910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。